Search Results

Real-World Evidence Study for the Safety and Effectiveness of Ribociclib in Combination with Hormonal Therapy in Patients with HR+/HER2- Advanced or Metastatic Breast Cancer in the Middle East Region Drug Clinical Trial

Important Information on the Correct Use of Spiriva and Foradil Capsules Awareness Article

A 24-week, multicentre, non-interventional, prospective study to describe clinical outcomes of advancing therapy with iGlarLixi in patients with T2DM sub-optimally controlled on basal insulin with or without OADs in daily practice in Saudi Arabia Drug Clinical Trial

A phase II randomized study of the combination of Ribociclib plus goserelin acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptorpositive/HER2-negative inoperable locally advanced or metastatic breast cancer – RIGHT Choice Study. Drug Clinical Trial

SFDA" Eliminates Manipulation of imported food products specifications via electronic registration of 600 Thousand Products Warnings

A Randomized, Double-Blind, Phase 3 Trial of Adagrasib plus Pembrolizumab plus Chemotherapy vs. Placebo plus Pembrolizumab plus Chemotherapy in Participants with Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer with KRAS G12C Mutation (KRYSTAL-4) Drug Clinical Trial

Roles and Responsibilities of Regulatory Bodies in Evaluating & Monitoring of Vaccine Safety: Focusing on COVID-19 Vaccines Workshop

A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of VX-880 in Subjects With Type 1 Diabetes With a Kidney Transplant Drug Clinical Trial

Randomized, Phase 3, double-blind, 52-week study to evaluate the efficacy and safety of rilzabrutinib (SAR444671) compared to placebo in adult participants with active IgG4- related disease Drug Clinical Trial

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients with Advancing Heart Failure Clinical Trial

Displaying 1811 - 1820 of 3079